Human Hypertension Aortic Fibroblasts
Quick Actions
Documentation 1 files
Product Overview
Description
Human Aortic Fibroblasts in hypertension are dynamic, multifunctional cells that drive vascular remodeling through ECM production, myofibroblast differentiation, inflammatory signaling, and crosstalk with immune and progenitor cells.
Their central role in aortic stiffening, fibrosis, and end-organ damage positions them as important therapeutic targets in the management of hypertension and its cardiovascular complications.
IMPORTANT: Quality warranty requires use of NeoBioPharma media. Biohazardous material despite negative pathogen testing. Quality claims must be reported within 1 month.
Key Features
Catalog Number: NBPH012
Product Format: Frozen
Vial Cell Number: > 5x10[5] cells/vial
Passage:1(P1)
Storage: Liquid Nitrogen, Vapor Phase
Intended Use: Research use only (RUO)
Characterization Markers
Cells test positive for the fibroblast-specific marker CD90 . They are negative for von Willebrand Factor (Factor VIII), cytokeratin 18, and alpha smooth muscle actin, confirming the absence of endothelial, epithelial, and smooth muscle cells.
Quick Facts
Product Type
Hypertension Fibroblasts Cells
Viability
>95% viable (Trypan Blue exclusion)
Applications
Research & Development
Availability
In Stock • Global Shipping
Technical Specifications
Applications & Use Cases
Research Areas
In Vitro Studies
Cell culture and screening applications
Molecular Biology
Gene expression & signaling studies
Drug Discovery
Screening & validation studies
Disease Modeling
Pathophysiology research
Support & Resources
Technical Support
Our experts are available for technical questions and protocol assistance.
Contact Support
